metricas
covid
Buscar en
Clínica e Investigación en Ginecología y Obstetricia
Toda la web
Inicio Clínica e Investigación en Ginecología y Obstetricia Sistema intrauterino de liberación de levonorgestrel en el tratamiento de la he...
Información de la revista
Vol. 30. Núm. 5.
Páginas 148-151 (enero 2003)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 30. Núm. 5.
Páginas 148-151 (enero 2003)
Acceso a texto completo
Sistema intrauterino de liberación de levonorgestrel en el tratamiento de la hemorragia uterina disfuncional
Visitas
5751
J. Lázaro, D. Rubio, J.J. Paniagua, L. Montoya
Servicio de Ginecología. Hospital Universitario Ramón y Cajal Madrid España
Este artículo ha recibido
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas
Summary

Introduction:Dysfunctional uterine bleeding is a common gynaecological condition for which medical treatment is often ineffective, and a large number of women undergo surgery.

Objective:To assess the effect of a levonorgestrel releasing intrauterine device in the management of menorrhagia.

Material and methods:The study included 47 premenopausal women with menorhagia. Menstrual loss was estimated with a pictographic chart and the measurement of serum haemoglobin and ferritin levels preinsertion and at six and twelve months postinsertion. We also evaluated the degree of satisfaction with the treatment.

Results:Menstrual blood loss was significantly reduced after six months (70%) and after twelve months the reduction was 78%. There was a significant increase in serum ferritin during the first year. The degree of satisfaction was high.

The degree of satisfaction was high. Conclusion:The levonorgestrel releasing intrauterine device is an effective nonsurgical treatment for the management of dysfunctional uterine bleeding and seems to be an important alternative to oral medication.

Resumen

La hemorragia uterina disfuncional es un trastornoginecológico frecuente en el que los tratamientos médicos son a menudo inefectivos y un gran número demujeres se somete a cirugía. Intentamos valorar elefecto de un sistema intrauterino de liberación de levonorgestrel en el tratamiento de la menorragia.

Se incluyen 47 mujeres premenopáusicas con menorragia. La pérdida menstrual fue estimada medianteuna tabla pictográfica y los niveles séricos de hemoglobina y ferritina antes de la inserción y a los 6 y 12meses postinserción. Valoramos el grado de satisfacción con el tratamiento.

La pérdida sanguínea menstrual se redujo de formasignificativa después de 6 meses (70%), y a los 12meses la reducción fue del 78%. Apreciamos un incremento significativo de la ferritina sérica durante elprimer año. El grado de satisfacción fue elevado.

El sistema intrauterino de liberación de levonorgestrel es un efectivo tratamiento no quirúrgico enel manejo de la hemorragia uterina disfuncional yse convierte en una alternativa importante a la medicación oral.

El Texto completo está disponible en PDF
Bibliografía
[1.]
IS Fraser, G McCarron, R. Markham.
A preliminary study of factors influencing perception of menstrual blood loss volume.
Am J Obstet Gynecol, 149 (1984), pp. 788-793
[2.]
C. Wood.
The association of psycho-social factors and gynaecological symptoms.
Aust Fam Physician, 7 (1978), pp. 471-478
[3.]
Lethaby A, Irvine G, Cameron I. Cyclical progestagens for heavy menstrual bleeding (Cochrane Review).: The Cochrane Library, Issue 2, 2000. Oxford: Update Software
[4.]
N Colacurci, G De Placido, M Galasso, A Mollo, A Perino, E. Cittadini.
The use of GnRH agonists depot for the treatment of dysfunctional uterine bleeding.
Acta Eur Fertil, 22 (1991), pp. 229-231
[5.]
B Andersch, I Milsom, G. Rybo.
An objective evaluation of flurbiprofen and tranexamic acid in the treatment of idiopathic menorrhagia.
Acta Obstet Gynecol Scand, 67 (1988), pp. 645-648
[6.]
OR. Kochli.
Endometrial ablation in the year 2000–do we have more methods than indications?.
Contrib Gynecol Obstet, 20 (2000), pp. 91-120
[7.]
J Lázaro, Bernal M González, L Montoya, M. Repollés.
Ablación endometrial: ¿cuál es la mejor alternativa?.
Cienc Ginecol, 4 (2002), pp. 208-217
[8.]
A Stewart, C Cummins, L Gold, R Jordan, W. Phillips.
The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review.
Br J Obstet Gynecol, 108 (2001), pp. 74-86
[9.]
T Maruo, JB Laoag-Fernandez, P Pakarinen, H Murakoshi, IM Spitz, E. Johansson.
Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium.
Hum Reprod, 16 (2001), pp. 2103-2108
[10.]
SG Silverberg, M Haukkamaa, H Arko, CG Nilsson, T Luukkainen, et al.
Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine device.
Inter J Gynecol Pathol, 5 (1986), pp. 235-241
[11.]
JK Andersson, G. Rybo.
Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia.
Br J Obstet Gynaecol, 97 (1990), pp. 690-694
[12.]
JM Higham, PMS O’Brien, RW. Shaw.
Assessment of menstrual blood loss using a pictorial chart.
Br J Obstet Gynaecol, 97 (1990), pp. 734-739
[13.]
I Milsom, K Andersson, B Andersch, G. Rybo.
A comparison of flurbiprofen, tranexamic acid and a levonorgestrelreleasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia.
Am J Obstet Gynecol, 164 (1991), pp. 879-883
[14.]
GWK Tang, SST. Lo.
Levonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women: efficacy versus acceptability.
Contraception, 51 (1995), pp. 231-235
[15.]
GA Irvine, MB Campbell-Brown, MA Lumsden, A Heikkilä, JJ Walker, IT. Cameron.
Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.
Br J Obstet Gynaecol, 105 (1998), pp. 592-598
[16.]
PG Crosignani, P Vercellini, P Mosconi, S Oldani, I Coztesi, O. De Giorgi.
Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding.
Obstet Gynecol, 90 (1997), pp. 257-263
[17.]
O Istre, B. Trolle.
Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection.
Fertil Steril, 76 (2001), pp. 304-309
[18.]
T. Römer.
Prospective comparison study of levonorgestrel IUD versus Roller-Ball endometrial ablation in the management of refractory recurrent hypermenorrhea.
Eur J Obstet Gynecol Reprod Biol, 90 (2000), pp. 27-29
[19.]
K Andersson, I Batar, G. Rybo.
Return to fertility after removal of a levonorgestrel releasing intrauterine device and NOVA T.
Contraception, 45 (1992), pp. 575-584
[20.]
T Luukkainen, P Lähteenmäki, J. Toivonen.
Levonorgestrel-releasing intrauterine device.
Annals of Medicine, 22 (1990), pp. 85-90
[21.]
JW Barrington, P. Bowen-Simpkins.
The levonorgestrel intrauterine system in the management of menorrhagia.
Br J Obstet Gynaecol, 104 (1997), pp. 614-616
[22.]
P Lätteenmäki, M Haukkamaa, J Puolakka, U Riikonen, S Sainio, J Suvisaari, et al.
Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy.
BMJ, 316 (1998), pp. 1122-1126
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos